These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
581 related articles for article (PubMed ID: 19747245)
1. Antitumor effect of photodynamic therapy in mice using direct application of Photofrin dissolved in lidocaine jelly. Murakami H; Kohno E; Kohmura Y; Ozawa H; Ito H; Sugihara K; Horiuchi K; Hirano T; Kanayama N Photodermatol Photoimmunol Photomed; 2009 Oct; 25(5):259-63. PubMed ID: 19747245 [TBL] [Abstract][Full Text] [Related]
2. Treatment with the tumor necrosis factor-alpha-inducing drug 5,6-dimethylxanthenone-4-acetic acid enhances the antitumor activity of the photodynamic therapy of RIF-1 mouse tumors. Bellnier DA; Gollnick SO; Camacho SH; Greco WR; Cheney RT Cancer Res; 2003 Nov; 63(22):7584-90. PubMed ID: 14633671 [TBL] [Abstract][Full Text] [Related]
3. Photodynamic therapy of human squamous cell carcinoma in vitro and in xenografts in nude mice. Megerian CA; Zaidi SI; Sprecher RC; Setrakian S; Stepnick DW; Oleinick NL; Mukhtar H Laryngoscope; 1993 Sep; 103(9):967-75. PubMed ID: 8361317 [TBL] [Abstract][Full Text] [Related]
4. Evidence for different mechanisms of EMT-6 tumor necrosis by photodynamic therapy with disulfonated aluminum phthalocyanine or photofrin: tumor cell survival and blood flow. Chan WS; Brasseur N; La Madeleine C; van Lier JE Anticancer Res; 1996; 16(4A):1887-92. PubMed ID: 8712717 [TBL] [Abstract][Full Text] [Related]
5. In vitro and in vivo photosensitizing applications of Photofrin in malignant melanoma cells. Chang CJ; Yu JS; Wei FC Chang Gung Med J; 2008; 31(3):260-7. PubMed ID: 18782948 [TBL] [Abstract][Full Text] [Related]
6. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model. Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481 [TBL] [Abstract][Full Text] [Related]
7. Comparison of photodynamic therapy with phthalocyanine and photofrin in human colorectal carcinoma. Stukavec J; Horak L; Duchac V; Jirasek T; Rakusan J; Karaskova M; Pouckova P Neoplasma; 2008; 55(2):127-9. PubMed ID: 18237250 [TBL] [Abstract][Full Text] [Related]
8. Anti-tumor effect of PDT using Photofrin in a mouse angiosarcoma model. Jin I; Yuji M; Yoshinori N; Makoto K; Mikio M Arch Dermatol Res; 2008 Apr; 300(4):161-6. PubMed ID: 18080130 [TBL] [Abstract][Full Text] [Related]
9. Clinical pharmacokinetics of the PDT photosensitizers porfimer sodium (Photofrin), 2-[1-hexyloxyethyl]-2-devinyl pyropheophorbide-a (Photochlor) and 5-ALA-induced protoporphyrin IX. Bellnier DA; Greco WR; Loewen GM; Nava H; Oseroff AR; Dougherty TJ Lasers Surg Med; 2006 Jun; 38(5):439-44. PubMed ID: 16634075 [TBL] [Abstract][Full Text] [Related]
10. Simultaneous two-photon excitation of photofrin in relation to photodynamic therapy. Karotki A; Khurana M; Lepock JR; Wilson BC Photochem Photobiol; 2006; 82(2):443-52. PubMed ID: 16613497 [TBL] [Abstract][Full Text] [Related]
11. Schedule-dependent interaction between Doxorubicin and mTHPC-mediated photodynamic therapy in murine hepatoma in vitro and in vivo. Kirveliene V; Grazeliene G; Dabkeviciene D; Micke I; Kirvelis D; Juodka B; Didziapetriene J Cancer Chemother Pharmacol; 2006 Jan; 57(1):65-72. PubMed ID: 16001168 [TBL] [Abstract][Full Text] [Related]
12. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Sitnik TM; Henderson BW Photochem Photobiol; 1998 Apr; 67(4):462-6. PubMed ID: 9559590 [TBL] [Abstract][Full Text] [Related]
13. Subclinical photodynamic therapy treatment modifies the brain microenvironment and promotes glioma growth. deCarvalho AC; Zhang X; Roberts C; Jiang F; Kalkanis SN; Hong X; Lu M; Chopp M Glia; 2007 Aug; 55(10):1053-60. PubMed ID: 17551928 [TBL] [Abstract][Full Text] [Related]
14. Photofrin photodynamic therapy: 2.0 mg/kg or not 2.0 mg/kg that is the question. Allison RR; Sibata CH Photodiagnosis Photodyn Ther; 2008 Jun; 5(2):112-9. PubMed ID: 19356641 [TBL] [Abstract][Full Text] [Related]
15. Tumor delivery of Photofrin® by PLL-g-PEG for photodynamic therapy. Kano A; Taniwaki Y; Nakamura I; Shimada N; Moriyama K; Maruyama A J Control Release; 2013 May; 167(3):315-21. PubMed ID: 23454112 [TBL] [Abstract][Full Text] [Related]
16. Photodynamic therapy: combined modality approaches targeting the tumor microenvironment. Gomer CJ; Ferrario A; Luna M; Rucker N; Wong S Lasers Surg Med; 2006 Jun; 38(5):516-21. PubMed ID: 16607618 [TBL] [Abstract][Full Text] [Related]
17. Combination of surgical resection and photodynamic therapy of 9L gliosarcoma in the nude rat. Zhang X; Jiang F; Kalkanis SN; Yang H; Zhang Z; Katakowski M; Hong X; Zheng X; Chopp M Photochem Photobiol; 2006; 82(6):1704-11. PubMed ID: 17007560 [TBL] [Abstract][Full Text] [Related]
18. [Clinical study of Photofrin photodynamic therapy for advanced cancers]. Li LB; Luo RC; Liao WJ; Zhang MJ; Zhou J; Liu XJ; Miao JX Di Yi Jun Yi Da Xue Xue Bao; 2003 Dec; 23(12):1341-3. PubMed ID: 14678909 [TBL] [Abstract][Full Text] [Related]
19. A comparative analysis of silicon phthalocyanine photosensitizers for in vivo photodynamic therapy of RIF-1 tumors in C3H mice. Anderson CY; Freye K; Tubesing KA; Li YS; Kenney ME; Mukhtar H; Elmets CA Photochem Photobiol; 1998 Mar; 67(3):332-6. PubMed ID: 9523532 [TBL] [Abstract][Full Text] [Related]
20. Inhibition of cyclooxygenase-2 indirectly potentiates antitumor effects of photodynamic therapy in mice. Makowski M; Grzela T; Niderla J; ŁAzarczyk M; Mróz P; Kopeé M; Legat M; Strusińska K; Koziak K; Nowis D; Mrówka P; Wasik M; Jakóbisiak M; Gołab J Clin Cancer Res; 2003 Nov; 9(14):5417-22. PubMed ID: 14614028 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]